Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19849988rdf:typepubmed:Citationlld:pubmed
pubmed-article:19849988lifeskim:mentionsumls-concept:C0917798lld:lifeskim
pubmed-article:19849988lifeskim:mentionsumls-concept:C0040594lld:lifeskim
pubmed-article:19849988lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:19849988lifeskim:mentionsumls-concept:C0310370lld:lifeskim
pubmed-article:19849988pubmed:issue10lld:pubmed
pubmed-article:19849988pubmed:dateCreated2009-10-23lld:pubmed
pubmed-article:19849988pubmed:abstractTextThrombolysis remains the main therapeutic strategy used in stroke, but with a limited use to only a part of stroke patients. A neuroprotective approach would be necessary with a double objective : (1) to serve as an add-on treatment with thrombolysis to improve safety and increase therapeutic window ; (2) to limit infarct area by delaying neuronal death. While numerous molecules failed in clinical trials in stroke, pharmacological development is on-going with pleiotropic drugs targeting both neuronal and vascular parts of neurovascular unit. Another approach targets the functional rehabilitation and the neurorepair using pharmacological ways or cell therapy.lld:pubmed
pubmed-article:19849988pubmed:languagefrelld:pubmed
pubmed-article:19849988pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19849988pubmed:citationSubsetIMlld:pubmed
pubmed-article:19849988pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19849988pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19849988pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19849988pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19849988pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19849988pubmed:statusMEDLINElld:pubmed
pubmed-article:19849988pubmed:monthOctlld:pubmed
pubmed-article:19849988pubmed:issn0767-0974lld:pubmed
pubmed-article:19849988pubmed:authorpubmed-author:OnténienteBri...lld:pubmed
pubmed-article:19849988pubmed:authorpubmed-author:HeurteauxCath...lld:pubmed
pubmed-article:19849988pubmed:authorpubmed-author:Charriaut-Mar...lld:pubmed
pubmed-article:19849988pubmed:authorpubmed-author:BordetRégisRlld:pubmed
pubmed-article:19849988pubmed:authorpubmed-author:OukThavarakTlld:pubmed
pubmed-article:19849988pubmed:issnTypePrintlld:pubmed
pubmed-article:19849988pubmed:volume25lld:pubmed
pubmed-article:19849988pubmed:ownerNLMlld:pubmed
pubmed-article:19849988pubmed:authorsCompleteYlld:pubmed
pubmed-article:19849988pubmed:pagination847-54lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:meshHeadingpubmed-meshheading:19849988...lld:pubmed
pubmed-article:19849988pubmed:year2009lld:pubmed
pubmed-article:19849988pubmed:articleTitle[Cerebral ischaemia: tomorrow's therapeutic tracks].lld:pubmed
pubmed-article:19849988pubmed:affiliationEA1046, département de pharmacologie médicale, Institut de médecine prédictive et de recherche thérapeutique, Université Lille-Nord de France, Faculté de médecine, Centre hospitalier et universitaire de Lille, 2, avenue Oscar Lambret 59037 Lille Cedex, France. r-bordet@chru-lille.frlld:pubmed
pubmed-article:19849988pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19849988pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:19849988pubmed:publicationTypeReviewlld:pubmed